English: Are Antipsychotics Neurotoxic or Neuroprotective? A Randomised Multicentre Longitudinal Study for Comparison of Two Therapy Strategies for the Treatment of Schizophrenia. - APIC

RWTH Aachen University represented by the Rector, represented by the Dean of the Medical Faculty0 个研究点目标入组 544 人开始时间: 2016年6月24日最近更新: 2020年11月30日

适应症

试验速览

暂无简介。

•1.Patients with diagnosis schizophrenia according to DSM-V
•2.Age 18-65 years
•3.Written declaration of consent
•4.Subjects being contractually and mentally capable to attend the medical staffs’ orders.
•5.MRI capability
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 65
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 65

•1.Relevant somatic diseases, which could have an impact on the conduct of the study based on clinical judgement of the treating physician (e.g. epilepsy, cancer)
•2.Prior insufficiently documented drug therapy with antipsychotics
•3.Magnetic metals in and on the body, cardiac pacemakers and body piercings.
•4.Pregnancy or lactation
•5.Hospitalization of the patient ordered by the court or public authorities
•6.Relationship of dependence or employment to sponsor or investigator
•8.Simultaneous participation in another clinical trial (participation in an APIC subproject excluded)

发起方

RWTH Aachen University represented by the Rector, represented by the Dean of the Medical Faculty